Nextcure, Inc.
Clinical trials sponsored by Nextcure, Inc., explained in plain language.
-
New targeted drug LNCB74 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug, LNCB74, in people with advanced solid tumors (ovarian, breast, endometrial, bile duct, or lung cancer) that have not responded to standard treatments. The drug is designed to deliver a cancer-killing agent directly to tumor cells. The main…
Phase: PHASE1 • Sponsor: NextCure, Inc. • Aim: Disease control
Last updated Jun 16, 2026 23:39 UTC
-
New drug SIM0505 enters first human tests for advanced cancers
Disease control Recruiting nowThis early-stage study tests a new drug, SIM0505, in about 414 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. Participants must have tried at le…
Phase: PHASE1 • Sponsor: NextCure, Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC